Specific synbiotics in early life protect against diet-induced obesity in adult mice

Diabetes, Obesity and Metabolism

Volumn 20, Issue 6, 2018, Pages 1408-1418

  Mischke, Mona ^a   Arora, Tulika ^b   Tims, Sebastian ^a   Engels, Eefje ^a   Sommer, Nina ^b   van Limpt, Kees ^a   Baars, Annemarie ^a   Oozeer, Raish ^a   Oosting, Annemarie ^a   Bäckhed, Fredrik ^b,c   Knol, Jan ^a,d  

^a DANONE NUTRICIA RESEARCH   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Capital Region   (Denmark)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

body composition; dietary intervention; insulin resistance; liver; mouse model; obesity therapy

Indexed keywords

PREBIOTIC AGENT; SYNBIOTIC AGENT; ANTIOBESITY AGENT; CHOLESTEROL;

ADOLESCENT; ADULT; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM BREVE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; DIET INDUCED OBESITY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FECES MICROFLORA; FEMALE; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HEALTH STATUS; INSULIN SENSITIVITY; INTESTINE FLORA; LIPID METABOLISM; LIPID STORAGE; MALE; METABOLISM; MOUSE; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; RISK FACTOR; SPECIES COMPOSITION; SYMBIONT; TRANSCRIPTOMICS; WESTERN DIET; ANIMAL; BLOOD; BODY CONSTITUTION; C57BL MOUSE; GLUCOSE BLOOD LEVEL; ILEUM; OBESITY; PHYSIOLOGY;

ANIMALS; ANTI-OBESITY AGENTS; BIFIDOBACTERIUM BREVE; BLOOD GLUCOSE; BODY CONSTITUTION; BODY WEIGHT; CHOLESTEROL; DIET, WESTERN; FEMALE; GASTROINTESTINAL MICROBIOME; ILEUM; LIPID METABOLISM; MALE; MICE, INBRED C57BL; OBESITY; PHENOTYPE; PREBIOTICS; SYNBIOTICS;

EID: 85043269295     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.13240     Document Type: Article

References (53)

1. WHO. Obesity and overweight fact sheet. June 2016; http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed October 18, 2017.
2. Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician. 2006;73:1961-1968.
3. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066-3072.
4. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242-249.
5. Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-546.
6. Wopereis H, Oozeer R, Knipping K, Belzer C, Knol J. The first thousand days - intestinal microbiology of early life: establishing a symbiosis. Pediatr Allergy Immunol. 2014;25:428-438.
7. Tarry-Adkins JL, Ozanne SE. Mechanisms of early life programming: current knowledge and future directions. Am J Clin Nutr. 2011;94(suppl 6):1765S-1771S.
8. Okubo H, Crozier SR, Harvey NC, et al. Diet quality across early childhood and adiposity at 6 years: the Southampton Women's Survey. Int J Obes (Lond). 2015;39:1456-1462.
9. Benyshek DC. The developmental origins of obesity and related health disorders--prenatal and perinatal factors. Coll Antropol. 2007;31:11-17.
10. Nauta AJ, Ben Amor K, Knol J, Garssen J, van der Beek EM. Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems. Am J Clin Nutr. 2013;98(suppl):586S-593S.
11. Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG. Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence. Pediatrics. 2005;115:1367-1377.
12. Arenz S, Ruckerl R, Koletzko B, von Kries R. Breast-feeding and childhood obesity--a systematic review. Int J Obes Relat Metab Disord. 2004;28:1247-1256.
13. Mott GE, Jackson EM, McMahan CA, McGill HC Jr. Cholesterol metabolism in adult baboons is influenced by infant diet. J Nutr. 1990;120:243-251.
14. Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511-521.
15. Ajslev TA, Andersen CS, Gamborg M, Sorensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond). 2011;35:522-529.
16. Azad MB, Bridgman SL, Becker AB, Kozyrskyj AL. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond). 2014;38:1290-1298.
17. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-1412.
18. Roberfroid M, Gibson GR, Hoyles L, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010;104(suppl 2):S1-S63.
19. Floch MH, Walker WA, Madsen K, et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol. 2011;45(suppl):S168-S171.
20. Kolida S, Gibson GR. Synbiotics in health and disease. Annu Rev Food Sci Technol. 2011;2:373-393.
21. Chua MC, Ben-Amor K, Lay C, et al. Effect of synbiotic on the gut microbiota of cesarean delivered infants: a randomized, double-blind, multicenter study. J Pediatr Gastroenterol Nutr. 2017;65:102-106.
22. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr. 2005;94:783-790.
23. Knol J, Scholtens P, Kafka C, et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40:36-42.
24. Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2005;71:2318-2324.
25. Koleva PT, Bridgman SL, Kozyrskyj AL. The infant gut microbiome: evidence for obesity risk and dietary intervention. Nutrients. 2015;7:2237-2260.
26. Oosting A, Kegler D, Boehm G, Jansen HT, van de Heijning BJ, van der Beek EM. N-3 long-chain polyunsaturated fatty acids prevent excessive fat deposition in adulthood in a mouse model of postnatal nutritional programming. Pediatr Res. 2010;68:494-499.
27. Oosting A, van Vlies N, Kegler D, et al. Effect of dietary lipid structure in early postnatal life on mouse adipose tissue development and function in adulthood. Br J Nutr. 2014;111:215-226.
28. Lin K, Kools H, de Groot PJ, et al. MADMAX - Management and analysis database for multiple ~omics experiments. J Integr Bioinform. 2011;8:160.
29. Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158:705-721.
30. Harvey BM, Langford JE, Harthoorn LF, et al. Effects on growth and tolerance and hypoallergenicity of an amino acid-based formula with synbiotics. Pediatr Res. 2014;75:343-351.
31. Abrahamse-Berkeveld M, Alles M, Franke-Beckmann E, et al. Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study. J Nutr Sci. 2016;5:e42.
32. Huet F, Abrahamse-Berkeveld M, Tims S, et al. Partly fermented infant formulae with specific oligosaccharides support adequate infant growth and are well-tolerated. J Pediatr Gastroenterol Nutr. 2016;63:e43-e53.
33. Decsi T, Arato A, Balogh M, et al. Randomised placebo controlled double blind study on the effect of prebiotic oligosaccharides on intestinal flora in healthy infants. Orv Hetil. 2005;146:2445-2450.
34. Schmelzle H, Wirth S, Skopnik H, et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr. 2003;36:343-351.
35. Costalos C, Kapiki A, Apostolou M, Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev. 2008;84:45-49.
36. Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015;104:30-37.
37. Owen CG, Whincup PH, Odoki K, Gilg JA, Cook DG. Infant feeding and blood cholesterol: a study in adolescents and a systematic review. Pediatrics. 2002;110:597-608.
38. Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond). 2010;34:1531-1537.
39. Karlsson Videhult F, Ohlund I, Stenlund H, Hernell O, West CE. Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age. Eur J Nutr. 2015;54:355-363.
40. Saez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A. Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. Int J Mol Sci. 2016;17:pii:E928.
41. Delzenne NM, Cani PD. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: potential interest of prebiotics. Int Dairy J. 2010;20:277-280.
42. Ishimwe N, Daliri EB, Lee BH, Fang F, Du G. The perspective on cholesterol-lowering mechanisms of probiotics. Mol Nutr Food Res. 2015;59:94-105.
43. Aggarwal J, Swami G, Kumar M. Probiotics and their effects on metabolic diseases: an update. J Clin Diagn Res. 2013;7:173-177.
44. Rabot S, Membrez M, Bruneau A, et al. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 2010;24:4948-4959.
45. Pugalendhi KV, Sudhakaran PR, Ramakrishnan S. Effect of antimicrobials on cholesterol synthesis and content in liver and small intestines. Indian J Exp Biol. 1992;30:152-154.
46. Dietschy JM, Weis HJ. Cholesterol synthesis by the gastrointestinal tract. Am J Clin Nutr. 1971;24:70-76.
47. Kruit JK, Groen AK, van Berkel TJ, Kuipers F. Emerging roles of the intestine in control of cholesterol metabolism. World J Gastroenterol. 2006;12:6429-6439.
48. Lou J, Zhou H, Li C, et al. ABCA1 and ABCG1 expression in the small intestine of type 2 diabetic rats. Lab Med. 2014;45:17-24.
49. Bomhof MR, Saha DC, Reid DT, Paul HA, Reimer RA. Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity (Silver Spring). 2014;22:763-771.
50. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91:814-819.
51. Scholtens PA, Alles MS, Bindels JG, van der Linde EG, Tolboom JJ, Knol J. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J Pediatr Gastroenterol Nutr. 2006;42:553-559.
52. Kalliomaki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008;87:534-538.
53. Korpela K, Zijlmans MA, Kuitunen M, et al. Childhood BMI in relation to microbiota in infancy and lifetime antibiotic use. Microbiome. 2017;5:26.